Is Frequent Lab Monitoring Necessary? Dr. Bella Mehta discusses abstract 2619, Safety Outcomes of Routine Blood Tests for Monitoring of Biologic and Targeted Synthetic Therapies in Inflammatory Arthritis Patients, presented at #ACR24. https://t.co/vwPueeAVhO https://t.co/5wyTahjMAu